Descripciones mejoradas de Syndetics:

In Psychopharmacology of Panic, a group of distinguished contributors review the epidemiology, biological basis, and current treatments of this disorder. Particular emphasis is given to new findings on the co-morbidity of panic, especially with depression. The most up-to-date information on the biochemical events involved in the provocation of panic attacks is presented, and the roles of serotonin, cholecystokinin, GABA, and noradrenalin are examined in detail. This knowledge opens up possibilities for novel treatments for panic disorder, and their potential is assessed by the contributors. It is only relatively recently that panic has been classified as a distinct psychiatric disorder and it now appears in the International Classification of Disease in ICD10.

Tabla de contenidos provista por Syndetics

• 1 Introduction
• 2 The Epidemiology of Frequent and Less Frequent Panic Attacks
• 3 Epidemiology of Panic
• 4 Symptomatology of Panic Disorder: An Attempt to Define the Panic-agoraphobic Spectrum Phenomenology
• 5 Grown Hormone Stimulation by Clonidine in Panic Disorder
• 6 Panic May Be a Misfiring Suffocation Alarm
• 7 Do Benzodiazepine Receptors Have a Causal Role in Panic Disorder?
• 8 Serotonergic Basis of Panic Disorder
• 9 Cholecystokinin and Panic Disorders
• 10 Changes in Biogenic Amine Neurotransmitters in Panic Disorder
• 11 A Psychobiological Model for Panic Including Models for the Mechanism
• Involved in the Regulation of Mood and Anxiety and Implications for Behavioral and Pharmacological Therapies

Notas de autor provistas por Syndetics

Stuart A.MontgomeryReader and Honorary Consultant, Academic Department of PsychiatrySt Mary's Hospital Medical School, London.